首页> 外文期刊>Nature >A new class of synthetic retinoid antibiotics effective against bacterial persisters
【24h】

A new class of synthetic retinoid antibiotics effective against bacterial persisters

机译:一类新的合成类视黄醇抗生素,可有效对抗细菌持久性物质

获取原文
获取原文并翻译 | 示例
           

摘要

A challenge in the treatment of Staphylococcus aureus infections is the high prevalence of methicillin-resistant S. aureus (MRSA) strains and the formation of non-growing, dormant 'persister' subpopulations that exhibit high levels of tolerance to antibiotics(1-3) and have a role in chronic or recurrent infections(4,5). As conventional antibiotics are not effective in the treatment of infections caused by such bacteria, novel antibacterial therapeutics are urgently required. Here we used a Caenorhabditis elegans-MRSA infection screen(6) to identify two synthetic retinoids, CD437 and CD1530, which kill both growing and persister MRSA cells by disrupting lipid bilayers. CD437 and CD1530 exhibit high killing rates, synergism with gentamicin, and a low probability of resistance selection. All-atom molecular dynamics simulations demonstrated that the ability of retinoids to penetrate and embed in lipid bilayers correlates with their bactericidal ability. An analogue of CD437 was found to retain anti-persister activity and show an improved cytotoxicity profile. Both CD437 and this analogue, alone or in combination with gentamicin, exhibit considerable efficacy in a mouse model of chronic MRSA infection. With further development and optimization, synthetic retinoids have the potential to become a new class of antimicrobials for the treatment of Gram-positive bacterial infections that are currently difficult to cure.
机译:治疗金黄色葡萄球菌感染的一个挑战是耐甲氧西林的金黄色葡萄球菌(MRSA)菌株的高流行以及形成对抗生素具有高水平耐受性的不生长的休眠``亚群''亚群(1-3)并在慢性或复发性感染中起作用(4,5)。由于常规抗生素不能有效治疗由此类细菌引起的感染,因此迫切需要新型抗菌疗法。在这里,我们使用秀丽隐杆线虫-MRSA感染筛选(6)来鉴定两种合成类视黄醇CD437和CD1530,它们通过破坏脂质双层来杀死生长中的MRSA细胞和持久性MRSA细胞。 CD437和CD1530具有较高的杀灭率,与庆大霉素的协同作用以及抗药性选择的可能性低。全原子分子动力学模拟表明,类维生素A渗透和嵌入脂质双层的能力与其杀菌能力有关。发现CD437的类似物保留了抗persister活性并显示出改善的细胞毒性特征。单独或与庆大霉素组合的CD437和该类似物在慢性MRSA感染的小鼠模型中均显示出相当大的功效。随着进一步的开发和优化,合成类维生素A有望成为一类新型的抗菌药物,用于治疗目前难以治愈的革兰氏阳性细菌感染。

著录项

  • 来源
    《Nature》 |2018年第7699期|103-107|共5页
  • 作者单位

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Brown Univ, Sch Engn, Providence, RI 02903 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA;

    Emory Univ, Dept Chem, Atlanta, GA 30322 USA;

    Emory Univ, Dept Chem, Atlanta, GA 30322 USA;

    Brown Univ, Sch Engn, Providence, RI 02903 USA;

    Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

    Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA;

    Emory Univ, Dept Chem, Atlanta, GA 30322 USA;

    Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA;

    Brown Univ, Sch Engn, Providence, RI 02903 USA;

    Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA;

    Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号